{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:21:50Z","timestamp":1794025310150,"version":"4.8.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"senior investigator"},{"name":"AFFIRMO"},{"name":"European Union\u2019s Horizon 2020 Research and Innovation Programme","award":["899871"],"award-info":[{"award-number":["899871"]}]},{"name":"University College London British Heart Foundation Research","award":["AA\/18\/6\/34223"],"award-info":[{"award-number":["AA\/18\/6\/34223"]}],"id":[{"id":"https:\/\/ror.org\/02jx3x895","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The CHA2DS2VASc score is recommended for stroke risk stratification in patients with atrial fibrillation (AF). This score assigns one extra point to female sex based on evidence from the early 2000s, suggesting higher thromboembolic risk in women. This incremental risk of thromboembolism in women has decreased over time between 2007 and 2018, becoming non-significant in recent years. The objective of this study was to assess the impact of removing the sex category (Sc) from the CHA2DS2VASc score, thus validating a non-sex CHA2DS2VASc (i.e. CHA2DS2VA) score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We analysed UK primary and secondary care data comprising 195 719 patients with AF followed between 1998 and 2016 (mean age: 75.9 \u00b1 12.3 years; 49.2% women). Among 126 428 non-anticoagulated patients, we compared the CHA2DS2VASc vs. CHA2DS2VA scores every calendar year. Throughout 413 007 patient-years, a total of 8742 events of ischaemic stroke or systemic embolism were recorded. Sex differences in thromboembolic risk were not observed in the lower-risk population, but higher stroke rates were consistently seen in female patients in the higher-risk category (i.e. CHA2DS2VA \u22652). C-statistics for both CHA2DS2VA and CHA2DS2VASc scores were similar over the years (ranging from 0.62 to 0.71). With CHA2DS2VA, no relevant differences were observed in integrated discrimination improvement, and net reclassification improvement (NRI) resulted in improved reclassification (11%) in lower thromboembolic risk groups. The NRI suggested misclassification in higher thromboembolic risk patients (\u22127%), but this did not affect their indication for anticoagulation (i.e. patients retained their high-risk status).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Removing Sc from the CHA2DS2VASc score does not affect its ability to discriminate thromboembolic events in the population with AF. The use of CHA2DS2VA may simplify initial decision-making for thromboprophylaxis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euae280","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:22:12Z","timestamp":1730506932000},"source":"Crossref","is-referenced-by-count":56,"title":["Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1991-5001","authenticated-orcid":false,"given":"Hiroyuki","family":"Yoshimura","sequence":"first","affiliation":[{"name":"Institute of Health Informatics Research, University College London , 222 Euston Road, London NW1 2DA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-9883","authenticated-orcid":false,"given":"Rui","family":"Providencia","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics Research, University College London , 222 Euston Road, London NW1 2DA ,","place":["UK"]},{"name":"Barts Heart Centre, Barts Health NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-1937","authenticated-orcid":false,"given":"Chris","family":"Finan","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-0424","authenticated-orcid":false,"given":"Amand Floriaan","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London , London ,","place":["UK"]},{"name":"Division Heart and Lungs, Department of Cardiology, University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital , Liverpool ,","place":["UK"]},{"name":"Department of Clinical Medicine, Danish Center for Health Services Research, Aalborg University , Aalborg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,10]]},"reference":[{"key":"2024112914585643600_euae280-B1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2024112914585643600_euae280-B2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024112914585643600_euae280-B3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"2024112914585643600_euae280-B4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/a-2325-5923","article-title":"2024 Chinese expert consensus guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (cardiovascular branch): executive summary","volume":"124","author":"Wang","year":"2024","journal-title":"Thromb Haemost"},{"key":"2024112914585643600_euae280-B5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2024112914585643600_euae280-B6","doi-asserted-by":"crossref","first-page":"e3522","DOI":"10.1136\/bmj.e3522","article-title":"Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study","volume":"344","author":"Friberg","year":"2012","journal-title":"BMJ"},{"key":"2024112914585643600_euae280-B7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/clc.23257","article-title":"Risk of ischemic stroke and utility of CHA2DS2-VASc score in women and men with atrial fibrillation","volume":"42","author":"Tomasdottir","year":"2019","journal-title":"Clin Cardiol"},{"key":"2024112914585643600_euae280-B8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"Wagstaff","year":"2014","journal-title":"QJM Int J Med"},{"key":"2024112914585643600_euae280-B9","first-page":"281","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","volume":"124","author":"Corica","year":"2023","journal-title":"Thromb Haemost"},{"key":"2024112914585643600_euae280-B10","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","volume":"45","author":"Teppo","year":"2024","journal-title":"Eur Heart J"},{"key":"2024112914585643600_euae280-B11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2024112914585643600_euae280-B12","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2024112914585643600_euae280-B13","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/ije\/dys188","article-title":"Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)","volume":"41","author":"Denaxas","year":"2012","journal-title":"Int J Epidemiol"},{"key":"2024112914585643600_euae280-B14"},{"key":"2024112914585643600_euae280-B15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1055\/s-0039-1683933","article-title":"Incident co-morbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): implications for reassessment of stroke risk in initially \u2018low-risk\u2019 patients","volume":"119","author":"Chao","year":"2019","journal-title":"Thromb Haemost"},{"key":"2024112914585643600_euae280-B16"},{"key":"2024112914585643600_euae280-B17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"2024112914585643600_euae280-B18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"2024112914585643600_euae280-B19","author":"Uno"},{"key":"2024112914585643600_euae280-B20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"key":"2024112914585643600_euae280-B21","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjcard.2013.11.057","article-title":"Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation","volume":"113","author":"Inoue","year":"2014","journal-title":"Am J Cardiol"},{"key":"2024112914585643600_euae280-B22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1253\/circj.CJ-14-0144","article-title":"Validation of CHA2DS2-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation:\u2014an analysis of the J-RHYTHM registry","volume":"78","author":"Okumura","year":"2014","journal-title":"Circ J"},{"key":"2024112914585643600_euae280-B23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/heartjnl-2019-315065","article-title":"Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation","volume":"106","author":"Wu","year":"2020","journal-title":"Heart"},{"key":"2024112914585643600_euae280-B24","doi-asserted-by":"crossref","first-page":"e015689","DOI":"10.1161\/JAHA.120.015689","article-title":"Sex differences in oral anticoagulation and outcomes of stroke and intracranial bleeding in newly diagnosed atrial fibrillation","volume":"9","author":"Yong","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2024112914585643600_euae280-B25","doi-asserted-by":"crossref","first-page":"e005801","DOI":"10.1161\/JAHA.117.005801","article-title":"Sex differences in the use of oral anticoagulants for atrial fibrillation: a report from the National Cardiovascular Data Registry (NCDR\u00ae) PINNACLE registry","volume":"6","author":"Thompson","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2024112914585643600_euae280-B26","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1060028018771264","article-title":"Gender differences in efficacy and safety of direct oral anticoagulants in atrial fibrillation: systematic review and network meta-analysis","volume":"52","author":"Raccah","year":"2018","journal-title":"Ann Pharmacother"},{"key":"2024112914585643600_euae280-B27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/clc.23452","article-title":"Impact of gender: rivaroxaban for patients with atrial fibrillation in the XANTUS real-world prospective study","volume":"43","author":"Camm","year":"2020","journal-title":"Clin Cardiol"},{"key":"2024112914585643600_euae280-B28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4070\/kcj.2021.0399","article-title":"Association of gender with clinical outcomes in a contemporary cohort of patients with atrial fibrillation receiving oral anticoagulants","volume":"52","author":"Kim","year":"2022","journal-title":"Korean Circ J"},{"key":"2024112914585643600_euae280-B29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCRESAHA.116.309115","article-title":"Decline in cardiovascular mortality: possible causes and implications","volume":"120","author":"Mensah","year":"2017","journal-title":"Circ Res"},{"key":"2024112914585643600_euae280-B30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.str.0000437068.30550.cf","article-title":"Factors influencing the decline in stroke mortality: a statement from the American Heart Association\/American Stroke Association","volume":"45","author":"Lackland","year":"2014","journal-title":"Stroke"},{"key":"2024112914585643600_euae280-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5089\/9798400224843.001","article-title":"Tackling gender inequality: definitions, trends, and policy designs","volume":"2022","author":"Shang","year":"2022","journal-title":"IMF Work Pap"},{"key":"2024112914585643600_euae280-B32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2022.03468","article-title":"Stroke in women: a review focused on epidemiology, risk factors, and outcomes","volume":"25","author":"Yoon","year":"2023","journal-title":"J Stroke"},{"key":"2024112914585643600_euae280-B33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCRESAHA.121.319915","article-title":"The impact of sex and gender on stroke","volume":"130","author":"Rexrode","year":"2022","journal-title":"Circ Res"},{"key":"2024112914585643600_euae280-B34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/HYPERTENSIONAHA.119.12729","article-title":"Sex differences in hypertension and stroke risk in the REasons for Geographic and Racial Differences in Stroke Study: a longitudinal cohort study","volume":"74","author":"Madsen","year":"2019","journal-title":"Hypertens"},{"key":"2024112914585643600_euae280-B35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/CIRCULATIONAHA.120.049360","article-title":"Sex differences in blood pressure associations with cardiovascular outcomes","volume":"143","author":"Ji","year":"2021","journal-title":"Circulation"},{"key":"2024112914585643600_euae280-B36","doi-asserted-by":"crossref","first-page":"e005562","DOI":"10.1161\/CIRCOUTCOMES.118.005562","article-title":"Sex differences in the use of statins in community practice","volume":"12","author":"Nanna","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2024112914585643600_euae280-B37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3389\/fneur.2019.00993","article-title":"Oral contraceptive use and increased risk of stroke: a dose\u2013response meta-analysis of observational studies","volume":"10","author":"Li","year":"2019","journal-title":"Front Neurol"},{"key":"2024112914585643600_euae280-B38","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1161\/STROKEAHA.121.038659","article-title":"Oral contraceptives, hormone replacement therapy, and stroke risk","volume":"53","author":"Johansson","year":"2022","journal-title":"Stroke"},{"key":"2024112914585643600_euae280-B39","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1161\/STROKEAHA.114.006668","article-title":"Hormone replacement therapy and adverse outcomes in women with atrial fibrillation","volume":"45","author":"Apostolakis","year":"2014","journal-title":"Stroke"},{"key":"2024112914585643600_euae280-B40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/STROKEAHA.118.021453","article-title":"CHA2DS2-VASc score and stroke prediction in atrial fibrillation in Whites, Blacks, and Hispanics","volume":"50","author":"Chen","year":"2019","journal-title":"Stroke"},{"key":"2024112914585643600_euae280-B41","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2015.07.026","article-title":"Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study from Taiwan","volume":"66","author":"Chao","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024112914585643600_euae280-B42","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/STROKEAHA.116.013880","article-title":"Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study","volume":"47","author":"Chao","year":"2016","journal-title":"Stroke"},{"key":"2024112914585643600_euae280-B43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"2024112914585643600_euae280-B44","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"2024112914585643600_euae280-B45","doi-asserted-by":"crossref","first-page":"euad226","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip","year":"2023","journal-title":"Europace"},{"key":"2024112914585643600_euae280-B46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"2024112914585643600_euae280-B47","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.314.7093.1529","article-title":"Population based study of use of anticoagulants among patients with atrial fibrillation in the community","volume":"314","author":"Sudlow","year":"1997","journal-title":"BMJ"},{"key":"2024112914585643600_euae280-B48","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/europace\/euaa126","article-title":"Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis","volume":"22","author":"Wu","year":"2020","journal-title":"Europace"},{"key":"2024112914585643600_euae280-B49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12561-014-9118-0","article-title":"The net reclassification index (NRI): a misleading measure of prediction improvement even with independent test data sets","volume":"7","author":"Pepe","year":"2015","journal-title":"Stat Biosci"},{"key":"2024112914585643600_euae280-B50","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/sim.9717","article-title":"Pitfalls of the concordance index for survival outcomes","volume":"42","author":"Hartman","year":"2023","journal-title":"Stat Med"},{"key":"2024112914585643600_euae280-B51","volume-title":"Improving the recording of ethnicity in health datasets exploring the views of community respondents and the healthcare workforce","author":"Bignall","year":"2022"},{"key":"2024112914585643600_euae280-B52","first-page":"7","article-title":"An investigation into over the counter painkiller use","volume":"1","author":"Cusack","year":"2021","journal-title":"Int Undergrad J Health Sci"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euae280\/60580760\/euae280.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/11\/euae280\/60832170\/euae280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/26\/11\/euae280\/60832170\/euae280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T09:59:27Z","timestamp":1732874367000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euae280\/7889057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euae280","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,11,1]]},"article-number":"euae280"}}